NCT05570266View on ClinicalTrials.gov

Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples

CompletedOBSERVATIONAL

Enrollment

322

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

January 10, 2023

Study Completion Date

May 25, 2023

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST

Breast Cancer Risk Prediction Software

Genotyping of known breast cancer-related markers (313 variants) will be conducted using a microarray genotyping chip (Genetic Risk). Survey answers will determine Gail Model scores and thus Clinical Risk Score.

Trial Locations (1)

12930

MRCC Siloam Hospitals Semanggi, Jakarta

All Listed Sponsors

collaborator

SJH Initiatives

UNKNOWN

collaborator

MRCCC Siloam Hospitals Semanggi

UNKNOWN

lead

Nalagenetics Pte Ltd

INDUSTRY

NCT05570266 - Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples | Biotech Hunter | Biotech Hunter